Skip to content
10-Q

Quarterly Report

CARGO Therapeutics, Inc.

0000950170-25-066940

← back to feed
Filed
May 8, 2025 12:00 AM ET
Period of report

On SEC.gov

Financials in this filing

Metric Period Value
Shares Outstanding Q1 2025 · May 2, 2025 46.11M sh
Shares Diluted Q1 2025 · Mar 31, 2025 47.85M sh
Shares Diluted Q1 2025 · Mar 31, 2024 41M sh
Capex Q1 2025 · Mar 31, 2025 $382K
Capex Q1 2025 · Mar 31, 2024 $1.29M
Operating Cash Flow Q1 2025 · Mar 31, 2025 −$37.69M
Operating Cash Flow Q1 2025 · Mar 31, 2024 −$30.15M
Cash And Equivalents Q1 2025 · Mar 31, 2025 $61.77M
Cash And Equivalents Q1 2025 · Dec 31, 2024 $64.38M
Cash And Equivalents Q1 2025 · Mar 31, 2024 $81.53M
Stockholders Equity Q1 2025 · Mar 31, 2025 $282.46M
Stockholders Equity Q1 2025 · Dec 31, 2024 $360.23M
Stockholders Equity Q1 2025 · Mar 31, 2024 $373.21M
Stockholders Equity Q1 2025 · Dec 31, 2023 $405.39M
Current Liabilities Q1 2025 · Mar 31, 2025 $51.55M
Current Liabilities Q1 2025 · Dec 31, 2024 $25.03M
Total Liabilities Q1 2025 · Mar 31, 2025 $79.5M
Total Liabilities Q1 2025 · Dec 31, 2024 $53.83M
Current Assets Q1 2025 · Mar 31, 2025 $324.81M
Current Assets Q1 2025 · Dec 31, 2024 $345.01M
Total Assets Q1 2025 · Mar 31, 2025 $361.96M
Total Assets Q1 2025 · Dec 31, 2024 $414.05M
Eps Diluted Q1 2025 · Mar 31, 2025 −$1.77
Eps Diluted Q1 2025 · Mar 31, 2024 −$0.87
Eps Basic Q1 2025 · Mar 31, 2025 −$1.77
Eps Basic Q1 2025 · Mar 31, 2024 −$0.87
Sga Expense Q1 2025 · Mar 31, 2025 $11.51M
Sga Expense Q1 2025 · Mar 31, 2024 $10.3M
Rd Expense Q1 2025 · Mar 31, 2025 $30.64M
Rd Expense Q1 2025 · Mar 31, 2024 $30.5M
Net Income Q1 2025 · Mar 31, 2025 −$84.5M
Net Income Q1 2025 · Mar 31, 2024 −$35.81M
Operating Income Q1 2025 · Mar 31, 2025 −$88.43M
Operating Income Q1 2025 · Mar 31, 2024 −$40.81M